Literature DB >> 26135244

Valuing Child Health Utility 9D Health States with Young Adults: Insights from a Time Trade Off Study.

Julie Ratcliffe1, Gang Chen2, Katherine Stevens3, Sandra Bradley4, Leah Couzner2, John Brazier3, Michael Sawyer5, Rachel Roberts6, Elisabeth Huynh7, Terry Flynn8.   

Abstract

OBJECTIVES: In contrast to the proliferation of studies incorporating health state values from adults of all ages, relatively few studies have reported upon the application of the time trade off (TTO) approach to generate health state values from populations of younger adults. This study sought to employ a conventional TTO approach to obtain values for a selection of Child Health Utility 9D (CHU9D) health states from a sample of young adults aged 18-29 years and to compare with the values generated from application of the original UK adult standard gamble scoring algorithm and the Australian adolescent scoring algorithm.
METHODS: A convenience sample of Flinders University undergraduate students aged 18-29 years were invited to participate in an interviewer administered conventional TTO task to value a series of five CHU9D health impairment states using the widely used variant developed by the York EQ-5D team.
RESULTS: A total of 152 students within the target age range were approached to participate in the study of whom n = 38 consented to participate, giving an overall participation rate of 25%. With the exception of one health state, the mean TTO values were consistently lower than those generated from application of the original scoring algorithm for the CHU9D elicited with adults of all ages. A significant proportion of participants (n = 17, 45%) considered the most severe CHU9D (PITS) state to be worse than death.
CONCLUSIONS: This study adds to a growing body of evidence indicating that the values attached to identical health states are typically lower for younger people in comparison with adults of all ages and dependent upon the elicitation method utilised. The values obtained are applicable for re-scaling raw CHU9D health state values obtained from younger adolescent samples using profile case best-worst scaling.

Entities:  

Mesh:

Year:  2015        PMID: 26135244     DOI: 10.1007/s40258-015-0184-3

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN: 1175-5652            Impact factor:   2.561


  20 in total

1.  Measuring Health-Related Quality of Life in Adolescent Populations: An Empirical Comparison of the CHU9D and the PedsQLTM 4.0 Short Form 15.

Authors:  Karin Dam Petersen; Gang Chen; Christine Mpundu-Kaambwa; Katherine Stevens; John Brazier; Julie Ratcliffe
Journal:  Patient       Date:  2018-02       Impact factor: 3.883

2.  Preference Elicitation Techniques Used in Valuing Children's Health-Related Quality-of-Life: A Systematic Review.

Authors:  Cate Bailey; Martin Howell; Kirsten Howard; Rosalie Viney; Rakhee Raghunandan; Amber Salisbury; Gang Chen; Joanna Coast; Jonathan C Craig; Nancy J Devlin; Elisabeth Huynh; Emily Lancsar; Brendan J Mulhern; Richard Norman; Stavros Petrou; Julie Ratcliffe; Deborah J Street
Journal:  Pharmacoeconomics       Date:  2022-05-27       Impact factor: 4.558

3.  In a Child's Shoes: Composite Time Trade-Off Valuations for EQ-5D-Y-3L with Different Proxy Perspectives.

Authors:  Stefan A Lipman; Brigitte A B Essers; Aureliano P Finch; Ayesha Sajjad; Peep F M Stalmeier; Bram Roudijk
Journal:  Pharmacoeconomics       Date:  2022-10-18       Impact factor: 4.558

4.  Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best-Worst Scaling.

Authors:  Kim Dalziel; Max Catchpool; Borja García-Lorenzo; Inigo Gorostiza; Richard Norman; Oliver Rivero-Arias
Journal:  Pharmacoeconomics       Date:  2020-05       Impact factor: 4.981

5.  Scoring the Child Health Utility 9D instrument: estimation of a Chinese child and adolescent-specific tariff.

Authors:  Gang Chen; Fei Xu; Elisabeth Huynh; Zhiyong Wang; Katherine Stevens; Julie Ratcliffe
Journal:  Qual Life Res       Date:  2018-10-29       Impact factor: 4.147

Review 6.  Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going?

Authors:  Donna Rowen; Oliver Rivero-Arias; Nancy Devlin; Julie Ratcliffe
Journal:  Pharmacoeconomics       Date:  2020-04       Impact factor: 4.981

7.  Model-Based Methods to Translate Adolescent Medicine Trials Network for HIV/AIDS Interventions Findings Into Policy Recommendations: Rationale and Protocol for a Modeling Core (ATN 161).

Authors:  Anne M Neilan; Kunjal Patel; Allison L Agwu; Ingrid V Bassett; K Rivet Amico; Catherine M Crespi; Aditya H Gaur; Keith J Horvath; Kimberly A Powers; H Jonathon Rendina; Lisa B Hightow-Weidman; Xiaoming Li; Sylvie Naar; Sharon Nachman; Jeffrey T Parsons; Kit N Simpson; Bonita F Stanton; Kenneth A Freedberg; Audrey C Bangs; Michael G Hudgens; Andrea L Ciaranello
Journal:  JMIR Res Protoc       Date:  2019-04-16

8.  Developing a new quality of life instrument with older people for economic evaluation in aged care: study protocol.

Authors:  Julie Ratcliffe; Ian Cameron; Emily Lancsar; Ruth Walker; Rachel Milte; Claire Louise Hutchinson; Kate Swaffer; Stuart Parker
Journal:  BMJ Open       Date:  2019-05-24       Impact factor: 2.692

9.  Changes in weight status, quality of life and behaviours of South Australian primary school children: results from the Obesity Prevention and Lifestyle (OPAL) community intervention program.

Authors:  Lucinda Bell; Shahid Ullah; Eva Leslie; Anthea Magarey; Timothy Olds; Julie Ratcliffe; Gang Chen; Michelle Miller; Michelle Jones; Lynne Cobiac
Journal:  BMC Public Health       Date:  2019-10-22       Impact factor: 3.295

10.  Cost-effectiveness of Frequent HIV Screening Among High-risk Young Men Who Have Sex With Men in the United States.

Authors:  Anne M Neilan; Alexander J B Bulteel; Sybil G Hosek; Julia H A Foote; Kenneth A Freedberg; Raphael J Landovitz; Rochelle P Walensky; Stephen C Resch; Pooyan Kazemian; A David Paltiel; Milton C Weinstein; Craig M Wilson; Andrea L Ciaranello
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.